RecruitingNot Applicable

Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

Uzbekistan30 participantsStarted 2022-04-22

Plain-language summary

The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age over 18 years and up to 70 years; * Signed informed consent for inclusion to the study; * End stage liver cirrhosis. Exclusion Criteria: * Pregnancy; * Extrahepatic factors influencing systemic hemostasis; * Concomitant hematological diseases affecting the hemostatic system; * Severe concomitant disorders.

What they're measuring

Thrombosis of vascular anastomosis

Timeframe: 1 month

Trial details

NCT IDNCT06169592

SponsorRepublican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-11-14

Contact for this trial

Azam Babadjanov, Professor

+998901751703 azambabadjanov@gmail.com

View on ClinicalTrials.gov More Liver Cirrhosis trials